A GIMEMA survey on therapeutic use and response rates of FLT3 inhibitors in acute myeloid leukemia: Insights from Italian real‐world practice

Abstract Given the limited data on the real‐life therapeutic use of feline McDonough sarcoma (FMS)‐like tyrosine kinase 3 (FLT3) inhibitors in Italy, we surveyed investigators at 59 Italian hematology centers to gain insight into the proportion of acute myeloid leukemia (AML) patients receiving FLT3...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Monica Messina, Alfonso Piciocchi, Leonardo M. Siena, Stefano Soddu, Francesco Buccisano, Cristina Mecucci, Giovanni Martinelli, Antonio Curti, Roberto Cairoli, Paola Fazi, Marco Vignetti, Maria Teresa Voso, Adriano Venditti, Anna Candoni
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Wiley 2024-12-01
Edice:	eJHaem
Témata:	acute myeloid leukemia FLT3 inhibitors gilteritinib midostaurin real‐world
On-line přístup:	https://doi.org/10.1002/jha2.1045
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!